| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/04/2006 | US20060095986 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 05/04/2006 | US20060095979 Transgenic mice containing CLCN4 chloride ion channel gene disruptions |
| 05/04/2006 | US20060095978 Screening assay |
| 05/04/2006 | US20060094865 Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions |
| 05/04/2006 | US20060094864 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
| 05/04/2006 | US20060094863 Nucleic acid capable of hybridizing, serving as a marker for diagnosing feline nephropathy |
| 05/04/2006 | US20060094862 Specificity exchangers that redirect antibodies to a pathogen |
| 05/04/2006 | US20060094655 Modified growth hormones |
| 05/04/2006 | US20060094653 Pancreatic polypeptide family motifs and polypeptides comprising the same |
| 05/04/2006 | US20060094652 Hybrid polypeptides with selectable properties |
| 05/04/2006 | US20060094649 Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions |
| 05/04/2006 | US20060094647 Treatment of inflammatory bowel disease using growth factors |
| 05/04/2006 | US20060094116 High-efficiency wild-type-free AAV helper functions |
| 05/04/2006 | US20060094101 Mk2 interacting proteins |
| 05/04/2006 | US20060094083 Probiotic microorganisms producing chimeric human growth hormone fused with Fc fragment of human IgG for oral delivery system and methods for producing them |
| 05/04/2006 | US20060094082 Induces modulation of immune system whereby composition stimulates production of macrophage inflammatory protein-3 alpha from hepatoctyes; use in treating hyperproliferative disease, respiratory disorders, cardiovascular disease, neurological conditions, autoimmune, infectious, gastrointestinal disorders |
| 05/04/2006 | US20060094079 Protein for blocking platelet adhesion |
| 05/04/2006 | US20060094055 RNA silencing in animals as an antiviral defense |
| 05/04/2006 | US20060094049 Stabilized viral envelope proteins and uses thereof |
| 05/04/2006 | US20060094047 Primer for use in amplifying nucleotide sequences coding odor membrane protein |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094037 Proteins related to schizophrenia and uses thereof |
| 05/04/2006 | US20060094030 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 05/04/2006 | US20060094006 Immunotherapy regimens in hiv-infected patients |
| 05/04/2006 | US20060093652 Collagen product with an alginate sheath and method for producing the same |
| 05/04/2006 | US20060093640 Using ultrafiltration and heparin affinity chromatography to recover bone morphogenic proteins for use in induction of bone formation |
| 05/04/2006 | US20060093628 Protein aggregate magnesium-ammonium phospholinoleate-palmitoleate anhydride immonomodulator, its production process and formulation |
| 05/04/2006 | US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant |
| 05/04/2006 | US20060093625 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and an orphanin polypeptide as a targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 05/04/2006 | US20060093622 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 05/04/2006 | US20060093617 Peptides for inducing a CTL and/or HTL response to hepatitis C virus |
| 05/04/2006 | US20060093615 polypeptide that binds to major histocompatibility complex (MHC) proteins and induces cytotoxic t lymphocytes when bound to MHC antigens; anticancer vaccines |
| 05/04/2006 | US20060093614 Platelet glycoprotein Ib alpha fusion polypeptides and methods of use thereof |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093603 ErbB4 antagonists |
| 05/04/2006 | US20060093602 Inflammatory mediator antagonists |
| 05/04/2006 | US20060093596 Genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 05/04/2006 | US20060093594 Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions |
| 05/04/2006 | US20060093579 Human recombinant beta-interferon with improved solubility |
| 05/04/2006 | US20060092760 Device for mixing and/or injecting cements |
| 05/04/2006 | CA2820140A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2592351A1 Transcriptional inhibitor for human k-ras gene |
| 05/04/2006 | CA2585965A1 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 05/04/2006 | CA2585364A1 A thymus-specific protein |
| 05/04/2006 | CA2585354A1 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 05/04/2006 | CA2585287A1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/04/2006 | CA2585011A1 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | CA2584814A1 Suppression of endogenous immunoglobulin expression in non-human transgenic animals |
| 05/04/2006 | CA2584804A1 Eph receptor tumor biomarkers |
| 05/04/2006 | CA2584785A1 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 05/04/2006 | CA2584732A1 Vwfa and/or ant_ig domain containing proteins |
| 05/04/2006 | CA2584157A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/04/2006 | CA2583026A1 Hcv vaccines for chronic hcv patients |
| 05/03/2006 | EP1652931A2 Recombinant adenoviruses, preparation and uses thereof for the treatment and/or prevention ofs cancers |
| 05/03/2006 | EP1652924A2 Polypeptide, cDNA encoding the same and use thereof |
| 05/03/2006 | EP1652923A1 Gene overexpressed in cancer |
| 05/03/2006 | EP1652922A1 Novel protein usable in screening drug for improving type 2 diabetes |
| 05/03/2006 | EP1652921A1 Rice transposon gene |
| 05/03/2006 | EP1652918A2 Methods for detecting protein interactions using conformationally constrained peptides |
| 05/03/2006 | EP1652858A1 Peptides for inducing a CTL and/or HTL response to hepatitis C virus |
| 05/03/2006 | EP1652857A2 Fusion protein of HIV regulatory/accessory proteins |
| 05/03/2006 | EP1652856A1 Stress proteins-derived peptides and method of use thereof |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652534A2 Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| 05/03/2006 | EP1652530A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 05/03/2006 | EP1651963A2 Monocarboxylate transporters expressed in cancer cells |
| 05/03/2006 | EP1651772A1 Breast cancer signatures |
| 05/03/2006 | EP1651768A2 Pichia methanolica secretory signal |
| 05/03/2006 | EP1651766A2 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 05/03/2006 | EP1651765A2 Protein from photobacterium damselae and use thereof |
| 05/03/2006 | EP1651760A1 Human blood proteins expressed in monocot seeds |
| 05/03/2006 | EP1651756A1 Scaffold-free self-organized 3d synthetic tissue |
| 05/03/2006 | EP1651750A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 05/03/2006 | EP1651673A2 Methods for use of an lkb1/strad/mo25 complex |
| 05/03/2006 | EP1651672A2 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 05/03/2006 | EP1651671A2 Epha2 t-cell epitope agonists and uses therefor |
| 05/03/2006 | EP1651670A2 Novel therapeutic fusion proteins |
| 05/03/2006 | EP1651669A1 Perfusion method for producing erythropoietin |
| 05/03/2006 | EP1651668A2 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
| 05/03/2006 | EP1651667A1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same |
| 05/03/2006 | EP1651666A1 Alphavirus-based cytomegalovirus vaccines |
| 05/03/2006 | EP1651665A1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 05/03/2006 | EP1651663A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 05/03/2006 | EP1651662A2 Antagonistic analogs of gh-rh (2003) |
| 05/03/2006 | EP1651660A2 Methods and compositions for targeted cleavage and recombination |
| 05/03/2006 | EP1651264A1 Subunit vaccine against respiratory syncytial virus infection |
| 05/03/2006 | EP1651263A2 Safe mutant viral vaccines |
| 05/03/2006 | EP1651258A2 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 05/03/2006 | EP1651166A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/03/2006 | EP1651161A2 Pharmaceutical compositions and methods for accelerating wound healing |
| 05/03/2006 | EP1553969B1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 05/03/2006 | EP1356080B1 Detection and identification of groups of bacteria |
| 05/03/2006 | EP1356069B1 Enhanced transfection system |
| 05/03/2006 | EP1244349B1 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/03/2006 | EP1240822B1 Diabetes onset model mammal |
| 05/03/2006 | EP1151007B1 A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method |
| 05/03/2006 | EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
| 05/03/2006 | EP1117799B1 Novel strains of the bacillus subtilis group for food fermentation |